VIDA - Hot Stock with new prostate procedure Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VIDA - Hot Stock with new prostate procedure

VIDA 0.00001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Yo Yo who wrote (540)	7/21/1998 7:30:00 PM
From: Roberts	Read Replies (1) of 564

You may be ignoring two important pieces of data: 1) the stock was issued via a private placement by the Company. The company avoided paying out a 6-7% gross spread. When a Company typically does a large secondary, the stock is priced generally at a discount to the closing price and the issuer receives only the net proceeds (after paying the gross spread to the underwriters). 2) the stock issued is unregistered. I too would demand a discount if I couldn't trade the stock. In terms of keeping jobs, I doubt that the institutional investors contributed more because management invested. A reading of the proxy demonstrates management's incentive to turn this company around. I also don't think this argument explains why all Board members made purchases as well. I agree that this quarter was bleak, but the Company does have $15.3 million of cash in the bank. It will survive until the reimbursement policies get established. The TUNA procedure when compared to traditional and innovative approaches for BHP is the most cost effective. HMOs and state medicare agencies will embrace it over time. - brian

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next